GO:0005829 | cytosol | 5.02e-05 | 7.24e-01 | 2.000 | 9 | 86 | 2496 |
GO:0042789 | mRNA transcription from RNA polymerase II promoter | 5.82e-05 | 8.39e-01 | 7.415 | 2 | 2 | 13 |
GO:0005654 | nucleoplasm | 1.90e-04 | 1.00e+00 | 2.621 | 6 | 64 | 1082 |
GO:0044212 | transcription regulatory region DNA binding | 4.07e-04 | 1.00e+00 | 4.308 | 3 | 17 | 168 |
GO:0051084 | 'de novo' posttranslational protein folding | 4.91e-04 | 1.00e+00 | 5.906 | 2 | 5 | 37 |
GO:0070664 | negative regulation of leukocyte proliferation | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0035732 | nitric oxide storage | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:1901985 | positive regulation of protein acetylation | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:2000016 | negative regulation of determination of dorsal identity | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0043969 | histone H2B acetylation | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0090308 | regulation of methylation-dependent chromatin silencing | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0090081 | regulation of heart induction by regulation of canonical Wnt signaling pathway | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0097057 | TRAF2-GSTP1 complex | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0060965 | negative regulation of gene silencing by miRNA | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0070026 | nitric oxide binding | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0060795 | cell fate commitment involved in formation of primary germ layer | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0060177 | regulation of angiotensin metabolic process | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0035731 | dinitrosyl-iron complex binding | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0035730 | S-nitrosoglutathione binding | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:2000629 | negative regulation of miRNA metabolic process | 9.01e-04 | 1.00e+00 | 10.116 | 1 | 1 | 1 |
GO:0008134 | transcription factor binding | 1.18e-03 | 1.00e+00 | 3.782 | 3 | 18 | 242 |
GO:0004832 | valine-tRNA ligase activity | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0071638 | negative regulation of monocyte chemotactic protein-1 production | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0060242 | contact inhibition | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0009890 | negative regulation of biosynthetic process | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0006438 | valyl-tRNA aminoacylation | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0009786 | regulation of asymmetric cell division | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0090043 | regulation of tubulin deacetylation | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 2 | 2 |
GO:0019207 | kinase regulator activity | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0071389 | cellular response to mineralocorticoid stimulus | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0014737 | positive regulation of muscle atrophy | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0035984 | cellular response to trichostatin A | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0044324 | regulation of transcription involved in anterior/posterior axis specification | 1.80e-03 | 1.00e+00 | 9.116 | 1 | 1 | 2 |
GO:0010467 | gene expression | 2.34e-03 | 1.00e+00 | 2.730 | 4 | 45 | 669 |
GO:0035726 | common myeloid progenitor cell proliferation | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0018076 | N-terminal peptidyl-lysine acetylation | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0051920 | peroxiredoxin activity | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0060913 | cardiac cell fate determination | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0010560 | positive regulation of glycoprotein biosynthetic process | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0003130 | BMP signaling pathway involved in heart induction | 2.70e-03 | 1.00e+00 | 8.531 | 1 | 1 | 3 |
GO:0003677 | DNA binding | 3.08e-03 | 1.00e+00 | 2.187 | 5 | 49 | 1218 |
GO:0097157 | pre-mRNA intronic binding | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0018393 | internal peptidyl-lysine acetylation | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0007021 | tubulin complex assembly | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0051771 | negative regulation of nitric-oxide synthase biosynthetic process | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0033269 | internode region of axon | 3.60e-03 | 1.00e+00 | 8.116 | 1 | 1 | 4 |
GO:0001714 | endodermal cell fate specification | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0043620 | regulation of DNA-templated transcription in response to stress | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 2 | 5 |
GO:0065004 | protein-DNA complex assembly | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0060298 | positive regulation of sarcomere organization | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0032025 | response to cobalt ion | 4.50e-03 | 1.00e+00 | 7.794 | 1 | 1 | 5 |
GO:0000278 | mitotic cell cycle | 4.62e-03 | 1.00e+00 | 3.090 | 3 | 15 | 391 |
GO:0032873 | negative regulation of stress-activated MAPK cascade | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 2 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 3 | 6 |
GO:0032691 | negative regulation of interleukin-1 beta production | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 1 | 6 |
GO:0008432 | JUN kinase binding | 5.40e-03 | 1.00e+00 | 7.531 | 1 | 1 | 6 |
GO:0032930 | positive regulation of superoxide anion generation | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 7 |
GO:0002161 | aminoacyl-tRNA editing activity | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 2 | 7 |
GO:0002674 | negative regulation of acute inflammatory response | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 7 |
GO:0006475 | internal protein amino acid acetylation | 6.29e-03 | 1.00e+00 | 7.308 | 1 | 1 | 7 |
GO:0000086 | G2/M transition of mitotic cell cycle | 6.43e-03 | 1.00e+00 | 4.028 | 2 | 4 | 136 |
GO:0006457 | protein folding | 7.09e-03 | 1.00e+00 | 3.956 | 2 | 7 | 143 |
GO:0032872 | regulation of stress-activated MAPK cascade | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 8 |
GO:0001955 | blood vessel maturation | 7.19e-03 | 1.00e+00 | 7.116 | 1 | 1 | 8 |
GO:0006974 | cellular response to DNA damage stimulus | 7.87e-03 | 1.00e+00 | 3.877 | 2 | 7 | 151 |
GO:0044267 | cellular protein metabolic process | 7.89e-03 | 1.00e+00 | 2.812 | 3 | 20 | 474 |
GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 9 |
GO:0006450 | regulation of translational fidelity | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 2 | 9 |
GO:0035259 | glucocorticoid receptor binding | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 9 |
GO:0045793 | positive regulation of cell size | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 2 | 9 |
GO:0000302 | response to reactive oxygen species | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 9 |
GO:0060765 | regulation of androgen receptor signaling pathway | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 9 |
GO:0006983 | ER overload response | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 1 | 9 |
GO:0005832 | chaperonin-containing T-complex | 8.09e-03 | 1.00e+00 | 6.946 | 1 | 2 | 9 |
GO:0002199 | zona pellucida receptor complex | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 2 | 10 |
GO:0035413 | positive regulation of catenin import into nucleus | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 2 | 10 |
GO:0016407 | acetyltransferase activity | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 2 | 10 |
GO:0006355 | regulation of transcription, DNA-templated | 9.80e-03 | 1.00e+00 | 2.154 | 4 | 43 | 997 |
GO:0009395 | phospholipid catabolic process | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 11 |
GO:0045662 | negative regulation of myoblast differentiation | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 3 | 11 |
GO:0043923 | positive regulation by host of viral transcription | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 11 |
GO:0004623 | phospholipase A2 activity | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 11 |
GO:0033160 | positive regulation of protein import into nucleus, translocation | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 3 | 11 |
GO:0042975 | peroxisome proliferator activated receptor binding | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 1 | 11 |
GO:0060391 | positive regulation of SMAD protein import into nucleus | 9.87e-03 | 1.00e+00 | 6.656 | 1 | 4 | 11 |
GO:0005667 | transcription factor complex | 1.05e-02 | 1.00e+00 | 3.664 | 2 | 17 | 175 |
GO:0003714 | transcription corepressor activity | 1.08e-02 | 1.00e+00 | 3.640 | 2 | 11 | 178 |
GO:0005838 | proteasome regulatory particle | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 1 | 12 |
GO:0035198 | miRNA binding | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 1 | 12 |
GO:0000266 | mitochondrial fission | 1.08e-02 | 1.00e+00 | 6.531 | 1 | 1 | 12 |
GO:0005515 | protein binding | 1.11e-02 | 1.00e+00 | 0.881 | 10 | 198 | 6024 |
GO:0043508 | negative regulation of JUN kinase activity | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 1 | 13 |
GO:0071480 | cellular response to gamma radiation | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 1 | 13 |
GO:0016746 | transferase activity, transferring acyl groups | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 1 | 13 |
GO:0051019 | mitogen-activated protein kinase binding | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 2 | 13 |
GO:0043409 | negative regulation of MAPK cascade | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 2 | 13 |
GO:0004602 | glutathione peroxidase activity | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 1 | 13 |
GO:0030234 | enzyme regulator activity | 1.17e-02 | 1.00e+00 | 6.415 | 1 | 2 | 13 |
GO:0044822 | poly(A) RNA binding | 1.20e-02 | 1.00e+00 | 2.071 | 4 | 50 | 1056 |
GO:0016209 | antioxidant activity | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 2 | 14 |
GO:0070542 | response to fatty acid | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 14 |
GO:0000242 | pericentriolar material | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 1 | 14 |
GO:0032993 | protein-DNA complex | 1.26e-02 | 1.00e+00 | 6.308 | 1 | 2 | 14 |
GO:0001824 | blastocyst development | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 2 | 15 |
GO:1990090 | cellular response to nerve growth factor stimulus | 1.34e-02 | 1.00e+00 | 6.209 | 1 | 1 | 15 |
GO:0042176 | regulation of protein catabolic process | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 2 | 16 |
GO:0043209 | myelin sheath | 1.43e-02 | 1.00e+00 | 6.116 | 1 | 1 | 16 |
GO:0009060 | aerobic respiration | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 1 | 17 |
GO:0070372 | regulation of ERK1 and ERK2 cascade | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 2 | 17 |
GO:0022624 | proteasome accessory complex | 1.52e-02 | 1.00e+00 | 6.028 | 1 | 1 | 17 |
GO:0042744 | hydrogen peroxide catabolic process | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 18 |
GO:0045773 | positive regulation of axon extension | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 18 |
GO:0033613 | activating transcription factor binding | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 3 | 18 |
GO:0004364 | glutathione transferase activity | 1.61e-02 | 1.00e+00 | 5.946 | 1 | 1 | 18 |
GO:0035257 | nuclear hormone receptor binding | 1.70e-02 | 1.00e+00 | 5.868 | 1 | 1 | 19 |
GO:0071549 | cellular response to dexamethasone stimulus | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 3 | 20 |
GO:0010942 | positive regulation of cell death | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 20 |
GO:0032757 | positive regulation of interleukin-8 production | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 20 |
GO:1901687 | glutathione derivative biosynthetic process | 1.79e-02 | 1.00e+00 | 5.794 | 1 | 1 | 20 |
GO:0003713 | transcription coactivator activity | 1.86e-02 | 1.00e+00 | 3.227 | 2 | 24 | 237 |
GO:0032967 | positive regulation of collagen biosynthetic process | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 3 | 21 |
GO:0045862 | positive regulation of proteolysis | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 2 | 21 |
GO:0000123 | histone acetyltransferase complex | 1.88e-02 | 1.00e+00 | 5.723 | 1 | 6 | 21 |
GO:0003823 | antigen binding | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 2 | 22 |
GO:0005720 | nuclear heterochromatin | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 2 | 22 |
GO:0048147 | negative regulation of fibroblast proliferation | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 1 | 22 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.97e-02 | 1.00e+00 | 5.656 | 1 | 2 | 22 |
GO:0005874 | microtubule | 2.04e-02 | 1.00e+00 | 3.156 | 2 | 7 | 249 |
GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress | 2.05e-02 | 1.00e+00 | 5.592 | 1 | 1 | 23 |
GO:0043388 | positive regulation of DNA binding | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 2 | 24 |
GO:0043425 | bHLH transcription factor binding | 2.14e-02 | 1.00e+00 | 5.531 | 1 | 1 | 24 |
GO:0051059 | NF-kappaB binding | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 3 | 25 |
GO:0007339 | binding of sperm to zona pellucida | 2.23e-02 | 1.00e+00 | 5.472 | 1 | 2 | 25 |
GO:0003700 | sequence-specific DNA binding transcription factor activity | 2.25e-02 | 1.00e+00 | 2.251 | 3 | 39 | 699 |
GO:0035329 | hippo signaling | 2.32e-02 | 1.00e+00 | 5.415 | 1 | 5 | 26 |
GO:0061418 | regulation of transcription from RNA polymerase II promoter in response to hypoxia | 2.32e-02 | 1.00e+00 | 5.415 | 1 | 1 | 26 |
GO:0051209 | release of sequestered calcium ion into cytosol | 2.32e-02 | 1.00e+00 | 5.415 | 1 | 1 | 26 |
GO:0048565 | digestive tract development | 2.32e-02 | 1.00e+00 | 5.415 | 1 | 2 | 26 |
GO:0032720 | negative regulation of tumor necrosis factor production | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 2 | 27 |
GO:0034612 | response to tumor necrosis factor | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 2 | 27 |
GO:0007017 | microtubule-based process | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 2 | 27 |
GO:0006749 | glutathione metabolic process | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 1 | 27 |
GO:0043967 | histone H4 acetylation | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 1 | 27 |
GO:0051258 | protein polymerization | 2.41e-02 | 1.00e+00 | 5.361 | 1 | 2 | 27 |
GO:0050714 | positive regulation of protein secretion | 2.50e-02 | 1.00e+00 | 5.308 | 1 | 3 | 28 |
GO:0005634 | nucleus | 2.51e-02 | 1.00e+00 | 0.961 | 8 | 159 | 4559 |
GO:0007005 | mitochondrion organization | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 30 |
GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 1 | 30 |
GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling | 2.67e-02 | 1.00e+00 | 5.209 | 1 | 2 | 30 |
GO:0042594 | response to starvation | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 4 | 31 |
GO:0070373 | negative regulation of ERK1 and ERK2 cascade | 2.76e-02 | 1.00e+00 | 5.161 | 1 | 1 | 31 |
GO:0043407 | negative regulation of MAP kinase activity | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 1 | 32 |
GO:0043491 | protein kinase B signaling | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 2 | 32 |
GO:1903507 | negative regulation of nucleic acid-templated transcription | 2.85e-02 | 1.00e+00 | 5.116 | 1 | 2 | 32 |
GO:0001756 | somitogenesis | 2.94e-02 | 1.00e+00 | 5.071 | 1 | 1 | 33 |
GO:0071333 | cellular response to glucose stimulus | 2.94e-02 | 1.00e+00 | 5.071 | 1 | 1 | 33 |
GO:0045944 | positive regulation of transcription from RNA polymerase II promoter | 3.09e-02 | 1.00e+00 | 2.077 | 3 | 41 | 789 |
GO:2001237 | negative regulation of extrinsic apoptotic signaling pathway | 3.11e-02 | 1.00e+00 | 4.986 | 1 | 2 | 35 |
GO:0001102 | RNA polymerase II activating transcription factor binding | 3.20e-02 | 1.00e+00 | 4.946 | 1 | 1 | 36 |
GO:0031490 | chromatin DNA binding | 3.37e-02 | 1.00e+00 | 4.868 | 1 | 2 | 38 |
GO:0032092 | positive regulation of protein binding | 3.37e-02 | 1.00e+00 | 4.868 | 1 | 2 | 38 |
GO:0050681 | androgen receptor binding | 3.37e-02 | 1.00e+00 | 4.868 | 1 | 1 | 38 |
GO:0046332 | SMAD binding | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 2 | 40 |
GO:0071320 | cellular response to cAMP | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 1 | 40 |
GO:0035019 | somatic stem cell maintenance | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 6 | 40 |
GO:0007519 | skeletal muscle tissue development | 3.55e-02 | 1.00e+00 | 4.794 | 1 | 2 | 40 |
GO:0070301 | cellular response to hydrogen peroxide | 3.63e-02 | 1.00e+00 | 4.758 | 1 | 2 | 41 |
GO:0006418 | tRNA aminoacylation for protein translation | 3.72e-02 | 1.00e+00 | 4.723 | 1 | 3 | 42 |
GO:0043565 | sequence-specific DNA binding | 3.76e-02 | 1.00e+00 | 2.681 | 2 | 11 | 346 |
GO:0004402 | histone acetyltransferase activity | 3.81e-02 | 1.00e+00 | 4.689 | 1 | 6 | 43 |
GO:0000979 | RNA polymerase II core promoter sequence-specific DNA binding | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 4 | 44 |
GO:0045727 | positive regulation of translation | 3.90e-02 | 1.00e+00 | 4.656 | 1 | 2 | 44 |
GO:0043966 | histone H3 acetylation | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 5 | 45 |
GO:0001047 | core promoter binding | 3.98e-02 | 1.00e+00 | 4.624 | 1 | 5 | 45 |
GO:0044297 | cell body | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 2 | 46 |
GO:0043525 | positive regulation of neuron apoptotic process | 4.07e-02 | 1.00e+00 | 4.592 | 1 | 4 | 46 |
GO:0001669 | acrosomal vesicle | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 2 | 49 |
GO:0035690 | cellular response to drug | 4.33e-02 | 1.00e+00 | 4.501 | 1 | 3 | 49 |
GO:0006521 | regulation of cellular amino acid metabolic process | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 1 | 50 |
GO:0006986 | response to unfolded protein | 4.42e-02 | 1.00e+00 | 4.472 | 1 | 4 | 50 |
GO:0034976 | response to endoplasmic reticulum stress | 4.50e-02 | 1.00e+00 | 4.443 | 1 | 2 | 51 |
GO:0045454 | cell redox homeostasis | 4.50e-02 | 1.00e+00 | 4.443 | 1 | 1 | 51 |
GO:0009611 | response to wounding | 4.59e-02 | 1.00e+00 | 4.415 | 1 | 5 | 52 |
GO:0007623 | circadian rhythm | 4.68e-02 | 1.00e+00 | 4.388 | 1 | 1 | 53 |
GO:0051592 | response to calcium ion | 4.85e-02 | 1.00e+00 | 4.334 | 1 | 1 | 55 |
GO:0002039 | p53 binding | 4.85e-02 | 1.00e+00 | 4.334 | 1 | 4 | 55 |
GO:0071300 | cellular response to retinoic acid | 4.85e-02 | 1.00e+00 | 4.334 | 1 | 1 | 55 |
GO:0043627 | response to estrogen | 4.93e-02 | 1.00e+00 | 4.308 | 1 | 5 | 56 |
GO:0070062 | extracellular vesicular exosome | 5.08e-02 | 1.00e+00 | 1.209 | 5 | 57 | 2400 |
GO:0000502 | proteasome complex | 5.11e-02 | 1.00e+00 | 4.258 | 1 | 3 | 58 |
GO:0006396 | RNA processing | 5.19e-02 | 1.00e+00 | 4.233 | 1 | 5 | 59 |
GO:0000786 | nucleosome | 5.19e-02 | 1.00e+00 | 4.233 | 1 | 2 | 59 |
GO:0043433 | negative regulation of sequence-specific DNA binding transcription factor activity | 5.19e-02 | 1.00e+00 | 4.233 | 1 | 6 | 59 |
GO:0008013 | beta-catenin binding | 5.28e-02 | 1.00e+00 | 4.209 | 1 | 9 | 60 |
GO:0006987 | activation of signaling protein activity involved in unfolded protein response | 5.36e-02 | 1.00e+00 | 4.185 | 1 | 2 | 61 |
GO:0032481 | positive regulation of type I interferon production | 5.36e-02 | 1.00e+00 | 4.185 | 1 | 6 | 61 |
GO:0043066 | negative regulation of apoptotic process | 5.43e-02 | 1.00e+00 | 2.388 | 2 | 16 | 424 |
GO:0043154 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic process | 5.53e-02 | 1.00e+00 | 4.138 | 1 | 4 | 63 |
GO:0005739 | mitochondrion | 5.60e-02 | 1.00e+00 | 1.738 | 3 | 23 | 998 |
GO:0006977 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest | 5.62e-02 | 1.00e+00 | 4.116 | 1 | 1 | 64 |
GO:0051436 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 5.71e-02 | 1.00e+00 | 4.093 | 1 | 2 | 65 |
GO:0006469 | negative regulation of protein kinase activity | 5.71e-02 | 1.00e+00 | 4.093 | 1 | 4 | 65 |
GO:0010468 | regulation of gene expression | 5.96e-02 | 1.00e+00 | 4.028 | 1 | 2 | 68 |
GO:0051437 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.13e-02 | 1.00e+00 | 3.986 | 1 | 2 | 70 |
GO:0006334 | nucleosome assembly | 6.30e-02 | 1.00e+00 | 3.946 | 1 | 3 | 72 |
GO:0002479 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent | 6.30e-02 | 1.00e+00 | 3.946 | 1 | 1 | 72 |
GO:0030324 | lung development | 6.30e-02 | 1.00e+00 | 3.946 | 1 | 1 | 72 |
GO:0000785 | chromatin | 6.39e-02 | 1.00e+00 | 3.926 | 1 | 6 | 73 |
GO:0000981 | sequence-specific DNA binding RNA polymerase II transcription factor activity | 6.47e-02 | 1.00e+00 | 3.906 | 1 | 4 | 74 |
GO:0051439 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle | 6.47e-02 | 1.00e+00 | 3.906 | 1 | 2 | 74 |
GO:0043161 | proteasome-mediated ubiquitin-dependent protein catabolic process | 6.56e-02 | 1.00e+00 | 3.887 | 1 | 1 | 75 |
GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I | 6.56e-02 | 1.00e+00 | 3.887 | 1 | 1 | 75 |
GO:0001889 | liver development | 6.72e-02 | 1.00e+00 | 3.849 | 1 | 3 | 77 |
GO:0005929 | cilium | 6.72e-02 | 1.00e+00 | 3.849 | 1 | 2 | 77 |
GO:0071013 | catalytic step 2 spliceosome | 6.81e-02 | 1.00e+00 | 3.830 | 1 | 7 | 78 |
GO:0030968 | endoplasmic reticulum unfolded protein response | 6.89e-02 | 1.00e+00 | 3.812 | 1 | 2 | 79 |
GO:0031145 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process | 6.89e-02 | 1.00e+00 | 3.812 | 1 | 2 | 79 |
GO:0071222 | cellular response to lipopolysaccharide | 7.06e-02 | 1.00e+00 | 3.776 | 1 | 4 | 81 |
GO:0009653 | anatomical structure morphogenesis | 7.23e-02 | 1.00e+00 | 3.741 | 1 | 2 | 83 |
GO:0009887 | organ morphogenesis | 7.48e-02 | 1.00e+00 | 3.689 | 1 | 5 | 86 |
GO:0090090 | negative regulation of canonical Wnt signaling pathway | 7.48e-02 | 1.00e+00 | 3.689 | 1 | 8 | 86 |
GO:0045471 | response to ethanol | 7.48e-02 | 1.00e+00 | 3.689 | 1 | 3 | 86 |
GO:0006979 | response to oxidative stress | 7.57e-02 | 1.00e+00 | 3.673 | 1 | 6 | 87 |
GO:0005200 | structural constituent of cytoskeleton | 7.90e-02 | 1.00e+00 | 3.608 | 1 | 6 | 91 |
GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I | 7.99e-02 | 1.00e+00 | 3.592 | 1 | 1 | 92 |
GO:0001649 | osteoblast differentiation | 7.99e-02 | 1.00e+00 | 3.592 | 1 | 5 | 92 |
GO:0071456 | cellular response to hypoxia | 7.99e-02 | 1.00e+00 | 3.592 | 1 | 3 | 92 |
GO:0051091 | positive regulation of sequence-specific DNA binding transcription factor activity | 7.99e-02 | 1.00e+00 | 3.592 | 1 | 7 | 92 |
GO:0051082 | unfolded protein binding | 8.07e-02 | 1.00e+00 | 3.576 | 1 | 7 | 93 |
GO:0005770 | late endosome | 8.07e-02 | 1.00e+00 | 3.576 | 1 | 2 | 93 |
GO:0016032 | viral process | 8.15e-02 | 1.00e+00 | 2.055 | 2 | 26 | 534 |
GO:0007417 | central nervous system development | 8.32e-02 | 1.00e+00 | 3.531 | 1 | 5 | 96 |
GO:0051726 | regulation of cell cycle | 8.40e-02 | 1.00e+00 | 3.516 | 1 | 5 | 97 |
GO:0006915 | apoptotic process | 8.71e-02 | 1.00e+00 | 1.999 | 2 | 12 | 555 |
GO:0006805 | xenobiotic metabolic process | 8.90e-02 | 1.00e+00 | 3.429 | 1 | 2 | 103 |
GO:0001934 | positive regulation of protein phosphorylation | 8.98e-02 | 1.00e+00 | 3.415 | 1 | 5 | 104 |
GO:0016023 | cytoplasmic membrane-bounded vesicle | 9.07e-02 | 1.00e+00 | 3.401 | 1 | 8 | 105 |
GO:0005737 | cytoplasm | 9.60e-02 | 1.00e+00 | 0.821 | 6 | 124 | 3767 |
GO:0030529 | ribonucleoprotein complex | 9.64e-02 | 1.00e+00 | 3.308 | 1 | 5 | 112 |
GO:0000209 | protein polyubiquitination | 9.97e-02 | 1.00e+00 | 3.258 | 1 | 3 | 116 |
GO:0006325 | chromatin organization | 1.01e-01 | 1.00e+00 | 3.233 | 1 | 12 | 118 |
GO:0007219 | Notch signaling pathway | 1.03e-01 | 1.00e+00 | 3.209 | 1 | 5 | 120 |
GO:0005524 | ATP binding | 1.05e-01 | 1.00e+00 | 1.359 | 3 | 31 | 1298 |
GO:0007050 | cell cycle arrest | 1.06e-01 | 1.00e+00 | 3.161 | 1 | 5 | 124 |
GO:0031982 | vesicle | 1.12e-01 | 1.00e+00 | 3.082 | 1 | 3 | 131 |
GO:0016055 | Wnt signaling pathway | 1.18e-01 | 1.00e+00 | 3.007 | 1 | 4 | 138 |
GO:0007507 | heart development | 1.18e-01 | 1.00e+00 | 2.997 | 1 | 7 | 139 |
GO:0001666 | response to hypoxia | 1.26e-01 | 1.00e+00 | 2.896 | 1 | 7 | 149 |
GO:0000082 | G1/S transition of mitotic cell cycle | 1.26e-01 | 1.00e+00 | 2.896 | 1 | 3 | 149 |
GO:0042981 | regulation of apoptotic process | 1.27e-01 | 1.00e+00 | 2.887 | 1 | 4 | 150 |
GO:0000398 | mRNA splicing, via spliceosome | 1.38e-01 | 1.00e+00 | 2.758 | 1 | 15 | 164 |
GO:0000978 | RNA polymerase II core promoter proximal region sequence-specific DNA binding | 1.39e-01 | 1.00e+00 | 2.749 | 1 | 12 | 165 |
GO:0034641 | cellular nitrogen compound metabolic process | 1.44e-01 | 1.00e+00 | 2.698 | 1 | 2 | 171 |
GO:0005764 | lysosome | 1.44e-01 | 1.00e+00 | 2.689 | 1 | 2 | 172 |
GO:0031625 | ubiquitin protein ligase binding | 1.49e-01 | 1.00e+00 | 2.640 | 1 | 5 | 178 |
GO:0032403 | protein complex binding | 1.53e-01 | 1.00e+00 | 2.600 | 1 | 6 | 183 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.54e-01 | 1.00e+00 | 2.592 | 1 | 22 | 184 |
GO:0003924 | GTPase activity | 1.64e-01 | 1.00e+00 | 2.494 | 1 | 7 | 197 |
GO:0005622 | intracellular | 1.71e-01 | 1.00e+00 | 2.422 | 1 | 6 | 207 |
GO:0006184 | GTP catabolic process | 1.77e-01 | 1.00e+00 | 2.374 | 1 | 7 | 214 |
GO:0016071 | mRNA metabolic process | 1.83e-01 | 1.00e+00 | 2.315 | 1 | 8 | 223 |
GO:0016020 | membrane | 1.87e-01 | 1.00e+00 | 0.986 | 3 | 46 | 1681 |
GO:0008380 | RNA splicing | 1.87e-01 | 1.00e+00 | 2.283 | 1 | 22 | 228 |
GO:0007399 | nervous system development | 1.89e-01 | 1.00e+00 | 2.264 | 1 | 6 | 231 |
GO:0043025 | neuronal cell body | 2.00e-01 | 1.00e+00 | 2.179 | 1 | 9 | 245 |
GO:0016070 | RNA metabolic process | 2.01e-01 | 1.00e+00 | 2.167 | 1 | 8 | 247 |
GO:0005615 | extracellular space | 2.12e-01 | 1.00e+00 | 1.213 | 2 | 20 | 957 |
GO:0005525 | GTP binding | 2.46e-01 | 1.00e+00 | 1.840 | 1 | 12 | 310 |
GO:0005813 | centrosome | 2.57e-01 | 1.00e+00 | 1.767 | 1 | 7 | 326 |
GO:0003682 | chromatin binding | 2.58e-01 | 1.00e+00 | 1.762 | 1 | 19 | 327 |
GO:0008283 | cell proliferation | 2.59e-01 | 1.00e+00 | 1.758 | 1 | 14 | 328 |
GO:0003723 | RNA binding | 2.68e-01 | 1.00e+00 | 1.698 | 1 | 18 | 342 |
GO:0046982 | protein heterodimerization activity | 2.93e-01 | 1.00e+00 | 1.546 | 1 | 8 | 380 |
GO:0044281 | small molecule metabolic process | 2.99e-01 | 1.00e+00 | 0.874 | 2 | 20 | 1211 |
GO:0009986 | cell surface | 3.08e-01 | 1.00e+00 | 1.465 | 1 | 9 | 402 |
GO:0045892 | negative regulation of transcription, DNA-templated | 3.15e-01 | 1.00e+00 | 1.426 | 1 | 24 | 413 |
GO:0006366 | transcription from RNA polymerase II promoter | 3.18e-01 | 1.00e+00 | 1.405 | 1 | 30 | 419 |
GO:0055114 | oxidation-reduction process | 3.19e-01 | 1.00e+00 | 1.401 | 1 | 10 | 420 |
GO:0045893 | positive regulation of transcription, DNA-templated | 3.55e-01 | 1.00e+00 | 1.215 | 1 | 24 | 478 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 4.08e-01 | 1.00e+00 | 0.961 | 1 | 37 | 570 |
GO:0045087 | innate immune response | 4.22e-01 | 1.00e+00 | 0.896 | 1 | 15 | 596 |
GO:0005794 | Golgi apparatus | 4.30e-01 | 1.00e+00 | 0.863 | 1 | 9 | 610 |
GO:0005730 | nucleolus | 4.45e-01 | 1.00e+00 | 0.435 | 2 | 66 | 1641 |
GO:0008270 | zinc ion binding | 6.06e-01 | 1.00e+00 | 0.154 | 1 | 27 | 997 |
GO:0005886 | plasma membrane | 7.05e-01 | 1.00e+00 | -0.219 | 2 | 49 | 2582 |
GO:0006351 | transcription, DNA-templated | 7.47e-01 | 1.00e+00 | -0.382 | 1 | 57 | 1446 |